ENArchives par auteur goodcorporation
Losing a contract because something goes wrong is a business headache that most organisations strive to avoid. This doesn’t just apply at a business-to-business level but forms, in theory, a crucial element of law enforcement. Under the EU Procurement Directive companies convicted of economic crimes such as bribery, fraud or money laundering are excluded from…
In many circles it is widely held that business and regulation are polar opposites: the latter restraining the former to prevent free enterprise and economic growth. What is less widely acknowledged perhaps is that often it is not regulation per se that hampers business, but bad regulation. Good regulation, in fact, can be welcomed by…
Moves to boost transparency in the relationships between healthcare professionals and pharmaceutical companies come into fruition this year. Michael Littlechild spoke to Pharma Times about the challenges and opportunities that disclosure will create. PharmaTimes – February 2016
The debate began by asking what we mean by a ‘good’ company? In English, ‘good’ has both a moral and a practical meaning; we talk about doing the right thing and how well something works. While these are two distinct concepts, there is a philosophical argument that suggests that the two are inextricably linked. Applied…
Frances House, Deputy Executive Director of the Institute for Human Rights and Business (IHRB) introduced GoodCorporation’s Business Ethics Debate on Business and Human Rights with an overview of the work of the IHRB and a recap of the Modern Slavery Act. The Institute of Human Rights and Business is a “think and do” tank with…
Shockwaves from the Toshiba accounting scandal were felt way beyond the company. The scandal dealt a blow not just to directors, employees and shareholders, but also to the Japanese president Shinzo Abe and his attempts to reform the country’s corporate governance practices. A recent study of corporate governance in 25 leading nations by KPMG and…
The emissions scandal at Volkswagen reveals how costly a lapse in ethical judgement can be. It has been argued that neither the firm’s supervisory board nor its executive committee where doing their job properly. But what should boards and investors be doing to ensure that such misconduct cannot go unchecked. Our Opinion Piece in The…
Karen Borrer, Head of Reputation at the Association of the British Pharmaceutical Industry (ABPI), opened GoodCorporation’s autumn Business Ethics Debate with an overview of the disclosure requirements, from June 2016, regarding transfers of value made to healthcare professionals (HCPs) during 2015. This comes in response to worldwide societal expectations of greater transparency across all industries….
The debate began with the suggestion that one way to minimise the risks is for organisations to work together to take industry-wide action (collective action) that sets the standards for good conduct in a particular sector. Antti Heinonen, chairman of the Banknote Ethics Initiative (BnEI) and a former director of the European Central Bank opened…
